The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
SUBSTITUTED IMIDAZOPYRIDINES AS INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
申请人:Shire Human Genetic Therapies, Inc.
公开号:EP3765459A1
公开(公告)日:2021-01-20
Tubulin Binding Anti Cancer Agents And Prodrugs Thereof
申请人:Matteucci Mark
公开号:US20090042820A1
公开(公告)日:2009-02-12
Novel tubulin binding compounds and hypoxia activated prodrugs of novel and known tubulin binding compounds useful for treating cancer and other hyperproliferative diseases are disclosed.
[EN] SUBSTITUTED IMIDAZOPYRIDINES AS INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF<br/>[FR] IMIDAZOPYRIDINES SUBSTITUÉES EN TANT QU'INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE ET LEURS UTILISATIONS
申请人:SHIRE HUMAN GENETIC THERAPIES
公开号:WO2019178129A1
公开(公告)日:2019-09-19
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.